Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
α-13'-COOH, also known as α-13'-carboxychromanol, is a long-chain metabolite of α-tocopherol (vitamin E) formed through enzymatic degradation in the liver. It is detected in human serum, indicating its systemic bioavailability. This molecule exhibits a range of biological activities distinct from its precursor, including anti-inflammatory, anti-proliferative, and anti-atherogenic effects. It has shown chemopreventive potential in colon adenoma cells, anti-inflammatory properties in atopic dermatitis skin models, and accelerates wound healing in mouse models. Its mechanism of action involves modulating cytokine expression, affecting macrophage foam cell formation, and influencing pathways like MAPK and NFκB. It also impacts lipid metabolism and can induce P-glycoprotein expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on α-13'-COOH.